<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AFederal_Trade_Commission_%28FTC%29_review</id>
	<title>Definition:Federal Trade Commission (FTC) review - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AFederal_Trade_Commission_%28FTC%29_review"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Federal_Trade_Commission_(FTC)_review&amp;action=history"/>
	<updated>2026-06-13T20:17:33Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Federal_Trade_Commission_(FTC)_review&amp;diff=10155&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Federal_Trade_Commission_(FTC)_review&amp;diff=10155&amp;oldid=prev"/>
		<updated>2026-03-11T06:58:20Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏛️ &amp;#039;&amp;#039;&amp;#039;Federal Trade Commission (FTC) review&amp;#039;&amp;#039;&amp;#039; is the pre-merger examination conducted by the FTC under the [[Definition:Hart-Scott-Rodino Act | Hart-Scott-Rodino Act]] to determine whether a proposed transaction — including mergers, acquisitions, and consolidations involving [[Definition:Insurance carrier | insurance carriers]], [[Definition:Insurance broker | brokers]], [[Definition:Managing general agent (MGA) | MGAs]], and [[Definition:Insurtech | insurtech]] firms — would substantially lessen competition or tend to create a monopoly in any relevant market. While the FTC shares [[Definition:Antitrust law | antitrust]] jurisdiction with the [[Definition:Department of Justice (DOJ) antitrust review | Department of Justice]], the two agencies divide responsibility by industry expertise; insurance-sector transactions may fall to either body depending on internal clearance protocols.&lt;br /&gt;
&lt;br /&gt;
⚙️ The process begins when the merging parties file an HSR notification along with the required filing fee once the transaction exceeds statutory thresholds. FTC staff then have an initial 30-day waiting period to review the filing, during which they assess [[Definition:Market concentration (insurance) | market concentration]] using tools like the [[Definition:Herfindahl-Hirschman Index (HHI) | Herfindahl-Hirschman Index]], analyze competitive overlaps in specific [[Definition:Line of business | lines of business]] or geographic territories, and evaluate barriers to entry. If concerns arise, the FTC issues a &amp;quot;second request&amp;quot; — a detailed demand for documents and data that can extend the review by months. For insurance deals, the data pull often includes [[Definition:Premium | premium]] volumes by state, [[Definition:Loss ratio (L/R) | loss ratios]], distribution agreements, and [[Definition:Reinsurance | reinsurance]] arrangements that illuminate how the combined entity would affect market dynamics.&lt;br /&gt;
&lt;br /&gt;
💡 Navigating an FTC review successfully requires insurance dealmakers to anticipate competitive concerns early — ideally during due diligence — and to prepare robust market-definition arguments. Because insurance markets can be defined narrowly (e.g., [[Definition:Professional liability insurance | professional liability]] for healthcare providers in the Southeast), a deal that looks benign on a national scale may raise red flags in a tightly drawn segment. Experienced counsel and economists who understand insurance-specific market definitions, [[Definition:Rate filing | rate-filing]] data, and the role of [[Definition:State insurance department | state insurance departments]] as concurrent regulators can make the difference between a smooth closing and a protracted investigation.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Department of Justice (DOJ) antitrust review]]&lt;br /&gt;
* [[Definition:Hart-Scott-Rodino Act]]&lt;br /&gt;
* [[Definition:Market concentration (insurance)]]&lt;br /&gt;
* [[Definition:Herfindahl-Hirschman Index (HHI)]]&lt;br /&gt;
* [[Definition:Competitive impact statement]]&lt;br /&gt;
* [[Definition:Multi-state regulatory approval]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>